Afferenz Enters 2006 with Vision for the Future of Clinical Trials; Strong Corporate Direction and Executive Leadership Position Afferenz at the Forefront of the Industry.

HERNDON, Va. -- Afferenz, a leading eClinical software and services company that addresses the information technology needs within the clinical trials environment, continues to change the way organizations execute their clinical development initiatives. Following a strong year of global growth, and experience in running ASP trials that dates back to 1999, 2006 marks Afferenz's transition from a hidden industry gem to one with a substantial market position. With a vision for end-to-end solutions for clinical development for today and beyond, Afferenz is determined to create the new standard for clinical data and trial management, and efficiencies in drug, biotechnology, and medical device development.

Following the 2002 transfer of intellectual property rights from Enmed, Inc., Afferenz was formed as the Life Sciences division of Megasoft Consultants Inc., an IP-driven technology solutions company committed to creating innovative product solutions. Today, Afferenz is a strategic business unit of Megasoft that continues to gather market momentum. From Phase I through to Phase IV trials, Afferenz's software and services are helping a global client roster that ranges from small biotechnology and medical device companies to industry-leading pharmaceutical companies and contract research organizations (CROs).

Ven Thangaraj, President of Afferenz, is responsible for driving the strategic direction of the company. His breadth and depth of knowledge and skills in information management and image processing have been demonstrated throughout his career. Prior to joining Afferenz in 2005, Thangaraj was founder, President, and Chief Technical Officer of Enmed, an e-Clinical software and service provider. Before founding Enmed, he was a founder and President of Integrated Medical Image Processing Systems, Inc., a company that developed online software for the post-processing of large medical data sets. Thangaraj also co-founded and served as President of Luminary Solutions, Inc., a software developer and IT consultancy specializing in corporate database and Intranet design, imaging applications development, and systems integration. As Vice President of Sales and Marketing, Kallol Biswas brings rich and varied experience within IT sales as part of a professional career spanning 21 years. Biswas has held senior positions in some of the biggest names in the IT industry, including WIPRO and IBM, and has more than 10 years of experience in global IT sales, including hardware, software and solutions.

At the heart of Afferenz's offering is the Acceliant(TM) eClinical Suite, a comprehensive solution that offers users real-time efficiency, ease-of-use in trial design, unparalleled flexibility, regulatory compliance, and the unique ability to integrate electronic data capture (EDC), online image analysis, and document management with traditional paper-based processes. Depending on the clinical and business needs of an organization, these solutions can be customized - and utilized independently or integrated - to provide complete, real-time data collection for every aspect of the clinical trial process, including eCRF generation, site, data, image, and document management. MedStudio, the Acceliant medical image management module and the industry's only data collection and medical image management workflows and analysis solution, integrates online digital medical images with patient CRFs and other clinical data and documents. By combining Acceliant with unmatched clinical, hosting, support, IT and consulting services, Afferenz can help an organization:

--Accelerate the clinical development critical path, while reducing the risk and cost of conducting clinical trials;

--Facilitate early market release of a new drug or therapy within its patent life; and,

--Simplify the clinical work flow process through a focused, single source partner.

"As life sciences companies continue to rework their clinical research processes, it is essential that they find a 'partner' with the technology, support and services tailored to their clinical processes and business objectives. Our mission at Afferenz is simple: to combine technology with process to accelerate clinical development through efficient trial, data, image and document management - the four cornerstones of the clinical trials environment," said Thangaraj. "Acceliant has been designed with unparalleled flexibility to easily complement and leverage - not replace - an organization's existing infrastructure and technology investments. And by offering the industry's only integrated data collection and medical image management workflows and analysis solution, we continue to define and shape the future of clinical development through innovation. We look forward to building on our past experience and success to continue to meet each organization's clinical requirements today - and beyond."

About Afferenz

Afferenz is a leading eClinical software and services company that addresses the information technology needs within the clinical trials environment. Afferenz's unique portfolio combines information technology with process to accelerate clinical development through efficient trial and data management. Afferenz' Acceliant(TM) eClinical Suite is a comprehensive solution that offers users real-time efficiency, ease-of-use in trial design, unparalleled flexibility, regulatory compliance, and the unique ability to integrate multi-modal electronic data capture (EDC), Data Management (CDMS), Trial Management (CTMS), online image analysis and document management with traditional paper-based processes. Headquartered in Herndon, Virginia, and with development centers in Chennai, India, Afferenz boasts a global client roster that includes industry-leading contract research organizations (CROs), pharmaceutical, biotechnology, and medical device companies. Additional information on the company can be found on its website: www.afferenz.com.